Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States (NCT07293559)
🩺 Plain-English Summary (8th-Grade Level)
IMPAACT 2046/UPLIFT (Understanding Practices of Lactation and Infant Feeding decisions Together with women with HIV) is a multi-site, mixed-methods, observational cohort study. The purpose of the study is to explore infant feeding preferences, practices, and outcomes among mothers with HIV and their families in the United States. It will employ both qualitative and quantitative research methods to address existing knowledge gaps and to understand the clinical, behavioral, and social factors influencing infant feeding decisions. As part of the study's mixed method approach, a longitudinal cohort study of mothers and their infants will be established. The study also aims to pilot a national registry of breastfeeding women living with HIV in the United States.
Who can join: Review the eligibility criteria below.
Location: University of Southern California (CRS 5048) — Los Angeles, California
🧪 Interventions in This Study
- No intervention provided in this study (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (11 Sites)
- University of Southern California (CRS 5048) — Los Angeles, California
- David Geffen School of Medicine at UCLA (CRS 5112) — Los Angeles, California
- University California, San Diego (CRS 4601) — San Diego, California
- University of Colorado, Denver (CRS 5052) — Aurora, Colorado
- University of Florida (5051) — Jacksonville, Florida
- Univ of Miami Pediatric/Perinatal HIV/AIDS (5127) — Miami, Florida
- 5030, Emory University School of Medicine Clinical Research Site — Atlanta, Georgia
- Lurie Children's Hospital of Chicago (CRS 4001) — Chicago, Illinois
- Johns Hopkins University (CRS 5092) — Baltimore, Maryland
- Jacobi Med. Ctr. Bronx NICHD CRS (5013) — The Bronx, New York
- St. Jude Childrens Research Hosp, Memphis (6501) — Memphis, Tennessee
📞 Contact the Study Coordinator
Phone: (202) 884-8480
Email: llevy@fhi360.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in HIV-1-infection
- Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1 — Washington D.C., District of Columbia
- Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen — Berkeley, California
- Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1 — Birmingham, Alabama
- Impact of HIV-1 and Aging on Mucosal Vaccine Responses — Aurora, Colorado
- Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed — Birmingham, Alabama
- Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy — Phoenix, Arizona
Explore by condition: All HIV-1-infection clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.